Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy

類似資料

• Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2(+) Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy
  著者:: Duchnowska, Renata, 等
  出版事項: (2012)
• Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
  著者:: Duchnowska, Renata, 等
  出版事項: (2017)
• Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
  著者:: Minuti, G, 等
  出版事項: (2012)
• Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases
  著者:: Duchnowska, Renata, 等
  出版事項: (2015)
• Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
  著者:: Duchnowska, Renata, 等
  出版事項: (2015)